Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.03+0.04 (+0.67%)
As of 09:50AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate-0.31-0.34-1.21-1.61
Low estimate-0.36-0.39-1.48-2
High estimate-0.27-0.3-0.89-1.08
Year ago EPS-1.47-0.2-1.57-1.21
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3334
Avg. Estimate1.07M1.13M28.47M24.41M
Low estimateN/AN/A10.65MN/A
High estimate3.2M3.4M64M67M
Year ago sales2.63M2.75M10.65M28.47M
Sales growth (year/est)-59.30%-59.00%167.30%-14.30%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.36-0.27-0.27-0.29
Actual EPS-1.47-0.2-0.35-0.28
Difference-1.110.07-0.080.01
Surprise %-308.30%25.90%-29.60%3.40%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.31-0.34-1.21-1.61
7 days ago-0.31-0.34-1.21-1.61
30 days ago-0.28-0.31-1.08-1.42
60 days ago-0.31-0.33-1.19-1.54
90 days ago-0.31-0.33-1.19-1.54
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLYELIndustrySector(s)S&P 500
Current qtr.78.90%N/AN/AN/A
Next qtr.-70.00%N/AN/AN/A
Current year22.90%N/AN/AN/A
Next year-33.10%N/AN/AN/A
Next 5 years (per annum)-7.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A